微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.3% | -75.1% | -82.76% | 45/69 | 2.26% | 羚锐制药 | 13.67% | 行业排名> |
| 2024-12-31 | 7.54% | -66.31% | -38.8% | 24/69 | 3.28% | 天目药业 | 9.27% | 行业排名> |
| 2024-09-30 | 12.32% | -36.63% | 34.2% | 12/69 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-06-30 | 9.18% | -27.32% | 75.86% | 8/69 | 0.66% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-03-31 | 5.22% | -43.32% | -76.68% | 9/69 | 1.53% | 羚锐制药 | 13.25% | 行业排名> |
| 2023-12-31 | 22.38% | 9.76% | 15.12% | 3/69 | 0.11% | 片仔癀 | 7.03% | 行业排名> |
| 2023-09-30 | 19.44% | 44.43% | 53.92% | 4/69 | 7.26% | 片仔癀 | 23.1% | 行业排名> |
| 2023-06-30 | 12.63% | 35.81% | 37.13% | 5/69 | 4.93% | 太极集团 | 22.08% | 行业排名> |
| 2023-03-31 | 9.21% | 60.45% | -54.83% | 2/69 | 3.21% | 太极集团 | 17.13% | 行业排名> |
| 2022-12-31 | 20.39% | 15.33% | 51.49% | 5/69 | 6.65% | 以岭药业 | 10.43% | 行业排名> |
| 2022-09-30 | 13.46% | 11.24% | 44.73% | 7/69 | 5.16% | *ST吉药 | 72.63% | 行业排名> |
| 2022-06-30 | 9.3% | 18.62% | 62.02% | 7/69 | 3.2% | 片仔癀 | 23.54% | 行业排名> |
| 2022-03-31 | 5.74% | -16.33% | -67.53% | 4/69 | 2.18% | 片仔癀 | 19.69% | 行业排名> |
| 2021-12-31 | 17.68% | 19.3% | 46.12% | 5/69 | 4.54% | 片仔癀 | 12.75% | 行业排名> |
| 2021-09-30 | 12.1% | 19.33% | 54.34% | 10/69 | 7.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-06-30 | 7.84% | 15.63% | 14.29% | 12/69 | 4.68% | 片仔癀 | 27.39% | 行业排名> |
| 2021-03-31 | 6.86% | 46.9% | -53.71% | 3/69 | 2.7% | 片仔癀 | 23.14% | 行业排名> |
| 2020-12-31 | 14.82% | -6.26% | 46.15% | 6/69 | 0.1% | 片仔癀 | 13.23% | 行业排名> |
| 2020-09-30 | 10.14% | -6.02% | 49.56% | 18/69 | 6.79% | *ST长药 | 7.37% | 行业排名> |
| 2020-06-30 | 6.78% | -25% | 45.18% | 12/69 | 3.75% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 4.67% | -3.91% | -70.46% | 6/69 | 2.14% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 15.81% | -0.5% | 46.52% | 7/69 | 5.86% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 10.79% | -0.92% | 19.36% | 13/69 | 7.3% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 9.04% | 9.58% | 86.01% | 6/69 | 4.72% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 4.86% | 1.67% | -69.41% | 6/69 | 2.92% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 15.89% | 22.61% | 45.91% | 10/69 | 7.87% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 10.89% | 21.81% | 32% | 14/69 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 8.25% | 23.5% | 72.59% | 7/69 | 5.03% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 4.78% | 30.6% | -63.12% | 5/69 | 2.75% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 12.96% | 40.56% | 44.97% | 19/69 | 9.93% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 8.94% | 81.34% | 33.83% | 26/69 | 8.39% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 6.68% | 30.72% | 82.51% | 24/69 | 5.24% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 3.66% | -5.18% | -60.3% | 20/69 | 2.62% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 9.22% | -15.02% | 87.02% | 37/69 | 10.02% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 4.93% | -42.41% | -3.52% | 42/69 | 9.32% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 5.11% | -30.76% | 32.38% | 34/69 | 5.04% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 3.86% | 3.49% | -64.42% | 19/69 | 4.1% | 维康药业 | 38.23% | 行业排名> |
| 2015-12-31 | 10.85% | -66.48% | 26.75% | 35/69 | 11.34% | 太极集团 | 58.41% | 行业排名> |
| 2015-09-30 | 8.56% | 2% | 15.99% | 31/69 | 8.44% | 新光药业 | 16.54% | 行业排名> |
| 2015-06-30 | 7.38% | -60.09% | 97.86% | 23/69 | 5.48% | 太极集团 | 71.6% | 行业排名> |
| 2015-03-31 | 3.73% | 2% | -88.48% | 18/69 | 2.9% | 维康药业 | 48.67% | 行业排名> |